Access For All: Adding MS DMTs to the WHO Essential Medicines List
The ECTRIMS Podcast - A podcast by The European Committee for Treatment and Research in Multiple Sclerosis
Everyone with MS should have access to the treatment and care that they need. Yet in 70% of countries, people face huge challenges in accessing disease modifying therapies (DMTs). Nick Rijke with the MS International Federation and Deanna Saylor of Johns Hopkins Hospital discuss a recent bid to add MS DMTs to the WHO's Essential Medicines List.
